DEERFIELD PARTNERS, L.P.

Insider Reports History

Location
New York, NY
Signature
/s/ Jonathan Isler, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by DEERFIELD PARTNERS, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nuvalent, Inc. Director, Director by Deputization, 10%+ Owner Class A Common Stock 650,000 $49,491,000 $76.14 03 Nov 2022 Direct
Larimar Therapeutics, Inc. Director, Dir. by Deputization/10% Group, 10%+ Owner Common Stock 2,777,777 $10,367,497 $3.73 16 Sep 2022 Direct

Insider Reports Filed by DEERFIELD PARTNERS, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NUVL Nuvalent, Inc. 03 Nov 2022 0 $0 3 Director, Director by Deputization, 10%+ Owner 07 Nov 2022, 17:23
LRMR Larimar Therapeutics, Inc. 16 Sep 2022 0 $0 3 Director, Dir. by Deputization/10% Group, 10%+ Owner 20 Sep 2022, 20:30